Lung Cancer Fight Club - 1st Round

The Champalimaud Foundation was created by the last will and testament of António de Sommer Champalimaud and is primarily dedicated to the development of biomedical research advanced programmes, and the provision of interdisciplinary clinical care, from a translational perspective based on the build-up of synergies and collaborations in all areas of activity.The Champalimaud Foundation focuses on cutting-edge research and strives to stimulate new discoveries and knowledge, which can improve the health and well-being of people around the world. The Champalimaud Centre for the Unknown, based in Lisbon, Portugal, hosts the Foundation’s activities in the fields of neuroscience and oncology by means of research programmes and the provision of clinical care of excellence. The fight against blindness is also supported through a focused outreach programme.It is also at the Champalimaud Centre for the Unknown that the Champalimaud Clinical Centre (CCC) develops its activity. In operation since 2011, the CCC is an advanced medical, scientific and technological institution, where, alongside integrated and interdisciplinary provision of specialised clinical oncological care, it also develops advanced programmes for translational research. Thus, the CCC seeks to customise therapy in order to improve the efficiency levels of disease control, survival rates and quality of life. As well as specialising in oncological pathologies, the CCC offers a full range of the most advanced treatment options and diagnostic tools, including radiology, pathology and nuclear medicine, which cut across all clinical situations, including everything from the most conventional to the most specialised tests.The Champalimaud Centre for the Unknown, besides being a state-of-the-art centre for multidisciplinary and translational research in the biomedicine field, also has unique facilities for hosting events. The combination of the architecture and its desirable location has made the Centre’s Auditorium one of Portugal’s most sought after venues for events and meetings.The Champalimaud Centre for the Unknown is a space created with the public in mind and where many of the spaces were designed to be used and enjoyed by all. In addition to the exotic interior garden, the Champalimaud Centre for the Unknown has opened large landscaped areas for public use, which surround the buildings along the riverbank. Perfectly integrated into the local area, these green spaces are intended to continue the redevelopment of the riverfront in total harmony. Likewise, the public footpath, which rises slowly before revealing a view of the sea, the open-air amphitheatre, and the infinity pool are already a recognised part of the city’s heritage. This is a place of choice and the perfect synergy between architecture, nature and local history.

Champalimaud Foundation

Champalimaud Lung Cancer Conference
Setembro 22, 2023
Lisbon/Portugal

<h2>Lung Cancer Fight Club - 1st Round</h2><h2>September 22, 2023</h2><h3>Lisbon/Portugal</h3><h3>Organising Committee: Inês Rolim * Joana Ip * Nuno Gil * Nuno Pimentel * Pedro Vaz * R﻿ita Barata * Susana Simões</h3><p>Dear Colleagues</p><p>On behalf of the Lung Unit Team of the Champalimaud Clinical Centre, we would like to invite you to participate in our first Lung Cancer Meeting - "Lung Cancer Fight Club -1st Round", which will take place in the Champalimaud Foundation Auditorium on 22nd September 2023.</p><p>Lung cancer is the leading cause of death from cancer worldwide conferring high morbidity, mortality and costs. In Portugal, the scenario is no different. According to the World Health Organisation (Globocan), in 2020, 5415 new cases of Lung Cancer were diagnosed in our country, being the 4th most frequently diagnosed tumour in both genders (the 2nd if breast and prostate neoplasms are excluded), with greater relevance in males. </p><p>The low survival rates for lung cancer reflect the high percentage of patients diagnosed with locally advanced or metastatic disease (75%), for whom the relative survival rate at 5 years is 6%, whereas in early stages of the disease it is approximately 60%. In Portugal, it is estimated that 23.6% of cases are diagnosed in locally advanced stage and 58.4% with metastatic disease. Therefore, the prognosis of the disease is highly dependent on the staging at diagnosis, which shows the great potential for the implementation of early diagnosis strategies in order to reduce this high mortality rate.</p><p>The delay in diagnosis of lung cancer is clearly an important factor on the overall outcome of the treatment of the disease, therefore efforts should be made to increase lung cancer diagnosis in early stages.  To achieve this goal, awareness-raising projects aimed at the general population and at health professionals, namely in General Practitioners, should be implemented. Along with this attitude, it is also of utmost importance to develop cancer registries, smoking cessation programmes and lung cancer screening on a large scale, optimising its cost-effectiveness and overcoming the considerable challenges that will be faced, particularly in the near future.</p><p>In the last decade, an increased number of new therapeutics, such as target therapies and immunotherapy, allowed a higher survival and better quality of life in patients diagnosed with advanced lung cancer. Recently, these new therapeutics are being applied in a perioperative setting, in lung cancer early stages. Ongoing trials showed highly promising preliminary results.</p><p>This meeting aims to assemble colleagues from different areas in the lung cancer field, for an enriching discussion about highlight subjects, such as prevention, screening, diagnosis and treatment, with a worthy commitment on the implementation of public health policies and interventions and the ultimate goal of doing more and better for our patients.</p><p>We look forward to seeing you at the Champalimaud Foundation on September 22, 2023.</p><p><a href="https://drive.google.com/file/d/1wq-VIxAFuG4TKedLX7kMCt_nw6bjedIt/view?usp=sharing" target="_blank" data-msys-clicktrack="0" rel="nofollow noopener noreferrer">P﻿ROGRAMME</a></p><p>The organising Committee</p>

Our {communityGuidelinesLink} describe the sort of content we prohibit on Eventbrite. If you suspect an event may be in violation, you can report it to us so we can investigate.

To report other categories of prohibited or illegal content, submit {link}